A Phase 1 interventional study of Alicaforsen in IBD, sponsored by Atlantic Pharmaceuticals Ltd. Completed at 1 site in United Kingdom. Open to male participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-07.
Sponsored by Atlantic Pharmaceuticals Ltd · Phase 1, Interventional, and Basic science
Phase 1 study to compare the effect of food on alicaforsen tablet.
A study on healthy male vounteers in a phase 1 unit. Alicaforsen tablets are gievn in a fed and fasted state
Exclusion Criteria:
Regimen A - Alicaforsen tablets with food
Drug: Alicaforsen
Regimen B - Alicaforsen tablets without food
Drug: Alicaforsen
Alicaforsen tablet
Pharmacokinetics
Area under the curve recovery of alicaforsen in plasma
Time frame: 24 hours
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Atlantic Pharmaceuticals Ltd